Volume 27, August 2016, Pages 65–67
Abstract
In
this short communication we present a re-analysis of homeopathic
patient data in comparison to control patient data from the same
Outpatient´s Unit “Homeopathy in malignant diseases” of the Medical
University of Vienna. In this analysis we took account of a probable
immortal time bias. For patients suffering from advanced stages of
cancer and surviving the first 6 or 12 months after diagnosis,
respectively, the results show that utilizing homeopathy gives a
statistically significant (p<0.001) advantage over control patients
regarding survival time. In conclusion, bearing in mind all limitations,
the results of this retrospective study suggest that patients with
advanced stages of cancer might benefit from additional homeopathic
treatment until a survival time of up to 12 months after diagnosis.
Keywords
- Additive homeopathy;
- Cancer;
- Immortal time bias;
- Landmark
© 2016 Elsevier Ltd. All rights reserved.